These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8207658)

  • 1. In vitro activity of readily available household materials against HIV-1: is bleach enough?
    Flynn N; Jain S; Keddie EM; Carlson JR; Jennings MB; Haverkos HW; Nassar N; Anderson R; Cohen S; Goldberg D
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):747-53. PubMed ID: 8207658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach.
    Shapshak P; McCoy CB; Shah SM; Page JB; Rivers JE; Weatherby NL; Chitwood DD; Mash DC
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):754-9. PubMed ID: 8207659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of varying concentrations of bleach on in vitro HIV-1 replication and the relevance to injection drug use.
    Contoreggi C; Jones S; Simpson P; Lange WR; Meyer WA
    Intervirology; 2000; 43(1):1-5. PubMed ID: 10773730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can HIV-1-contaminated syringes be disinfected? Implications for transmission among injection drug users.
    Abdala N; Gleghorn AA; Carney JM; Heimer R
    J Acquir Immune Defic Syndr; 2001 Dec; 28(5):487-94. PubMed ID: 11744839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 prevention: interdisciplinary studies on the efficacy of bleach and development of prevention protocols.
    McCoy CB; Shapshak P; Metsch LR; Rivers JE; McCoy HV; Weatherby NL; Shah SM; Chitwood DD
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):1-9. PubMed ID: 8744677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance to bleach disinfection protocols among injecting drug users in Miami.
    McCoy CB; Rivers JE; McCoy HV; Shapshak P; Weatherby NL; Chitwood DD; Page JB; Inciardi JA; McBride DC
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):773-6. PubMed ID: 8207662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing the transmission of HIV-1: needle bleaching as a means of disinfection.
    Romanelli F; Smith KM; Pomeroy C
    J Am Pharm Assoc (Wash); 2000; 40(6):812-7. PubMed ID: 11111361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of human immunodeficiency virus type 1 after rinsing injection syringes with different cleaning solutions.
    Abdala N; Crowe M; Tolstov Y; Heimer R
    Subst Use Misuse; 2004 Mar; 39(4):581-600. PubMed ID: 15115214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleach use and HIV seroconversion among New York City injection drug users.
    Titus S; Marmor M; Des Jarlais D; Kim M; Wolfe H; Beatrice S
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):700-4. PubMed ID: 8207647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Historical perspective on the use of bleach in HIV/AIDS prevention.
    Watters JK
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):743-6. PubMed ID: 8207657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Household bleach as disinfectant for use by injecting drug users.
    Watters JK; Jones TS; Shapshak P; McCoy CB; Flynn N; Gleghorn A; Vlahov D
    Lancet; 1993 Sep; 342(8873):742-3. PubMed ID: 8103844
    [No Abstract]   [Full Text] [Related]  

  • 12. Knowledge and practices among injecting-drug users of bleach use for equipment disinfection--New York City, 1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jun; 43(24):439, 445-6. PubMed ID: 8202077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Household bleach as disinfectant for use by injecting drug users.
    Hoffman PN; Layzell SK
    Lancet; 1993 Sep; 342(8873):743. PubMed ID: 8103846
    [No Abstract]   [Full Text] [Related]  

  • 14. Increasing the use of bleach and condoms among injecting drug users in Denver: outcomes of a targeted, community-level HIV prevention program.
    Rietmeijer CA; Kane MS; Simons PZ; Corby NH; Wolitski RJ; Higgins DL; Judson FN; Cohn DL
    AIDS; 1996 Mar; 10(3):291-8. PubMed ID: 8882669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV, drug-use paraphernalia, and bleach.
    Haverkos HW; Jones TS
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):741-2. PubMed ID: 8207656
    [No Abstract]   [Full Text] [Related]  

  • 16. Inadequate bleach contact times during syringe cleaning among injection drug users.
    Gleghorn AA; Doherty MC; Vlahov D; Celentano DD; Jones TS
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):767-72. PubMed ID: 8207661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panel sees bleach, an imperfect method, as better than nothing.
    AIDS Policy Law; 1995 Oct; 10(18):6. PubMed ID: 11362829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users?
    Kapadia F; Vlahov D; Des Jarlais DC; Strathdee SA; Ouellet L; Kerndt P; Morse E EV; Williams I; Garfein RS;
    Epidemiology; 2002 Nov; 13(6):738-41. PubMed ID: 12410020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disinfection of syringes contaminated with hepatitis C virus by rinsing with household products.
    Binka M; Paintsil E; Patel A; Lindenbach BD; Heimer R
    Open Forum Infect Dis; 2015 Jan; 2(1):ofv017. PubMed ID: 26034767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bloody needles: the volumes of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs.
    Gaughwin MD; Gowans E; Ali R; Burrell C
    AIDS; 1991 Aug; 5(8):1025-7. PubMed ID: 1777162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.